Invention Grant
- Patent Title: Primary cell gene editing
-
Application No.: US16782450Application Date: 2020-02-05
-
Publication No.: US10711283B2Publication Date: 2020-07-14
- Inventor: Kyle Jacoby , Alex Franzusoff
- Applicant: PACT PHARMA, INC.
- Applicant Address: US CA South San Francisco
- Assignee: PACT PHARMA, INC.
- Current Assignee: PACT PHARMA, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Baker Botts L.L.P.
- Main IPC: C12N15/90
- IPC: C12N15/90 ; C12N15/62 ; C12N15/85 ; C12N15/113 ; C07K14/725 ; A61K35/17
Abstract:
Methods and compositions are provided for nuclease-mediated gene editing of primary cells without the use of viral mediated delivery. Methods of treatments using edited primary cells are also provided.
Public/Granted literature
- US20200181650A1 PRIMARY CELL GENE EDITING Public/Granted day:2020-06-11
Information query
IPC分类:
